CG2001

· Beijing Dayspring Pharmaceutical Technology Co., Ltd

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CG2001, covering 2025-06-26 to 2026-03-03. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial to Evaluate CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia [Phase 2]